Nutritional Status and Physical Activity Levels in Adult Patients with Phenylketonuria

Damla Kalkan1, Yılmaz Yıldız2, Yiğitcan Karanfil3

  • 1Nutrition and Dietetic Department, Hacettepe University İhsan Doğramacı Children's Hospital, 06100 Ankara, Türkiye.

Nutrients
|June 12, 2026
PubMed

Insights

Adults with phenylketonuria (PKU) exhibit high rates of overweight and obesity, with physical activity influencing their nutritional status and metabolic control. Further research is needed to understand these complex relationships in managing PKU.

Area of Science:

  • Metabolic disorders
  • Nutritional science
  • Human physiology

Background:

  • Phenylketonuria (PKU) is an autosomal recessive disorder resulting from phenylalanine hydroxylase (PAH) deficiency.
  • Adult PKU patients often struggle with dietary adherence, leading to potential metabolic and nutritional issues.
  • Limited research exists on physical activity, nutritional status, and metabolic control in adult PKU populations.

Purpose of the Study:

  • To assess physical activity levels in adults with classical PKU.
  • To evaluate the nutritional status and anthropometric outcomes of these individuals.
  • To examine the relationship between physical activity, diet, and metabolic control in adult PKU.

Main Methods:

  • A cross-sectional study involving 100 adults with classical PKU.
  • Sociodemographic data and dietary intake assessed via interviews and 24-hour recalls.
  • Physical activity levels determined using the International Physical Activity Questionnaire (IPAQ).

Main Results:

  • High prevalence of overweight (39%) and obesity (16%) was observed in the study cohort.
  • 43% of participants met criteria for sufficient physical activity.
  • In men, higher physical activity correlated with increased energy intake, BMI, and use of Phe-free protein substitutes.

Conclusions:

  • Adults with classical PKU present with significant overweight/obesity rates and varied dietary and physical activity patterns.
  • Physical activity is linked to specific nutritional and metabolic factors in this population.
  • Long-term studies are necessary to fully elucidate the connections between physical activity and health outcomes in adult PKU.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...